Supriya Lifescience Limited

NSEI:SUPRIYA Stock Report

Market Cap: ₹58.7b

Supriya Lifescience Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure4.3yrs
Board average tenure5.4yrs

Recent management updates

Recent updates

Supriya Lifescience Limited (NSE:SUPRIYA) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Nov 07
Supriya Lifescience Limited (NSE:SUPRIYA) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Supriya Lifescience (NSE:SUPRIYA) Has Announced That It Will Be Increasing Its Dividend To ₹0.80

Sep 08
Supriya Lifescience (NSE:SUPRIYA) Has Announced That It Will Be Increasing Its Dividend To ₹0.80

We Think You Should Be Aware Of Some Concerning Factors In Supriya Lifescience's (NSE:SUPRIYA) Earnings

Jun 05
We Think You Should Be Aware Of Some Concerning Factors In Supriya Lifescience's (NSE:SUPRIYA) Earnings

Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings

May 10
Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings

Lacklustre Performance Is Driving Supriya Lifescience Limited's (NSE:SUPRIYA) Low P/E

Feb 09
Lacklustre Performance Is Driving Supriya Lifescience Limited's (NSE:SUPRIYA) Low P/E

Supriya Lifescience's (NSE:SUPRIYA) Shareholders May Want To Dig Deeper Than Statutory Profit

May 28
Supriya Lifescience's (NSE:SUPRIYA) Shareholders May Want To Dig Deeper Than Statutory Profit

Market Cool On Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings Pushing Shares 27% Lower

May 07
Market Cool On Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings Pushing Shares 27% Lower

CEO

Supriya Lifescience has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Satish Wagh
Founder16.8yrs₹11.65m67.64%
₹ 39.7b
Smita Wagh
Whole-time Director16.8yrs₹1.75m0.40%
₹ 234.8m
Saloni Wagh
Managing Director5.4yrs₹1.81m0.13%
₹ 74.7m
Shivani Wagh
Joint Managing Director5.4yrs₹1.81m0.13%
₹ 74.7m
Balasaheb Sawant
Whole Time Director1.6yrs₹632.00kno data
Krishna Raghunathan
Chief Financial Officer1.9yrs₹3.34mno data
Shireesh Ambhaikar
Technical Head2.2yrs₹892.00kno data
Sushanta Kumar Mishra
Chief Scientific Officer3.3yrsno datano data
Shweta Singh
Compliance Officer & Company Secretary5.3yrs₹940.00kno data
Prashant Zate
Head of Corporate Quality Assurance & Regulatory Affairs17.1yrsno datano data
Shekhar Bhirud
President - Business Development1.6yrsno datano data

4.3yrs

Average Tenure

60yo

Average Age

Experienced Management: SUPRIYA's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Satish Wagh
Founder16.8yrs₹11.65m67.64%
₹ 39.7b
Smita Wagh
Whole-time Director16.8yrs₹1.75m0.40%
₹ 234.8m
Saloni Wagh
Managing Director5.4yrs₹1.81m0.13%
₹ 74.7m
Shivani Wagh
Joint Managing Director5.4yrs₹1.81m0.13%
₹ 74.7m
Balasaheb Sawant
Whole Time Director1.6yrs₹632.00kno data
Neelam Arora
Independent Director3.8yrs₹12.00kno data
Dileep Jain
Independent Director3.8yrs₹16.00kno data
Dinesh Modi
Independent Director3.8yrs₹18.00kno data
Kedar Karmarkar
Independent Director9.8yrs₹17.00kno data
Bhairav Chokshi
Independent Director9.8yrs₹18.00kno data

5.4yrs

Average Tenure

62.5yo

Average Age

Experienced Board: SUPRIYA's board of directors are considered experienced (5.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 08:10
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Supriya Lifescience Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullK.R. Choksey Shares & Securities Private Ltd.